The Cross-Sectional Evaluation of the Use of Artemisinin-Based Combination Therapy for Treatment of Malaria Infection at a Tertiary Hospital in Nigeria

Table 4

Predictor variables for antimalarial drug coprescription with antibiotics.

Variable	Adjusted odds ratio	95% CI	value
Age group (years)
<5 years	Reference
5–11 years	0.16	0.04–0.61	0.007
12–18 years	0.20	0.04–1.03	0.055
>18 years	0.29	0.11–0.75	0.011
Gender
Female	Reference
Male	0.86	0.52–1.42	0.551
Treatment period
First quarter	Reference
Second quarter	0.87	0.48–1.58	0.650
Third quarter	0.94	0.51–1.72	0.837
Fourth quarter	1.72	0.44–6.76	0.441